REVIEW article
Front. Bioeng. Biotechnol.
Sec. Biomaterials
Volume 13 - 2025 | doi: 10.3389/fbioe.2025.1643222
This article is part of the Research TopicThe Application of Novel Biomaterials and Emerging Techniques in Musculoskeletal DisordersView all 4 articles
Innovative Strategies in Combating Intervertebral Disc Degeneration: Pathological Mechanisms and Biomaterial Advancements
Provisionally accepted
- 1Sanya Central Hospital, Sanya, China
- 2Guizhou Provincial People's Hospital, Guiyang, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Intervertebral disc degeneration (IVDD) is a leading cause of chronic low back pain, significantly impacting the quality of life for millions of individuals worldwide. The onset of IVDD is associated with various factors such as age, lifestyle, and genetics, and its pathological mechanisms involve multidimensional interactions, including oxidative stress, inflammation, and extracellular matrix (ECM) metabolic disorders. During degeneration, there is a reduction in the number of nucleus pulposus cells (NPCs), resulting in an imbalance between the synthesis and degradation of the ECM, leading to changes in the disc's morphology and biomechanical function, ultimately causing pain and mobility issues. As the global population ages, the incidence of IVDD continues to rise, necessitating the development of effective treatment strategies. Recent research into biomaterials, particularly hydrogels and stem cell technologies, has shown promise for disc regeneration, providing scaffolds to enhance cellular repair and facilitate drug delivery. This review comprehensively examines recent advancements in IVDD research, focusing on the pathological mechanisms and the potential application of biomaterials in treatment. Additionally, the integration of emerging technologies such as 3D printing and stem cell therapy represents a transformative approach in IVDD management.These findings open new avenues for targeted intervention strategies that address the underlying causes of IVDD, paving the way for improved clinical outcomes.
Keywords: Intervertebral disc degeneration1, oxidative stress2, Reactive Oxygen Species3, biomaterials4, regenerative medicine5
Received: 08 Jun 2025; Accepted: 31 Jul 2025.
Copyright: © 2025 Ma, Pan, Zhang and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Fashun Liu, Guizhou Provincial People's Hospital, Guiyang, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.